135 filings
Page 5 of 7
6-K
fqsp5qe3c8oy10wem
29 Apr 21
Silence Therapeutics Announces First Patient Dosed in GEMINI II Phase I Clinical Trial for SLN124
6:30am
6-K
qt345l8m
28 Apr 21
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases
7:46am
6-K
052z nmztr1aw5vye
19 Apr 21
Current report (foreign)
8:01am
424B4
aq0mt3b41e5mma 1drk
12 Apr 21
Prospectus supplement with pricing info
11:12am
424B4
yey1x1
12 Apr 21
Prospectus supplement with pricing info
11:11am
EFFECT
ex2z7zqqnt
9 Apr 21
Notice of effectiveness
12:15am
EFFECT
646xg4
9 Apr 21
Notice of effectiveness
12:15am
POS AM
0suis
8 Apr 21
Prospectus update (post-effective amendment)
9:31am
POS AM
9zlev9if0dd
8 Apr 21
Prospectus update (post-effective amendment)
9:18am
20-F
ceend x5xro
30 Mar 21
Annual report (foreign)
5:22pm
6-K
p4znay6p rutiw
30 Mar 21
Silence Therapeutics Reports Full-year 2020 Results
7:47am
424B7
i4wsdu97
15 Mar 21
Prospectus with selling stockholder info
10:07am
EFFECT
8oatl j894w
15 Mar 21
Notice of effectiveness
12:15am
F-1/A
cmm7is5
11 Mar 21
Registration statement (foreign) (amended)
4:02pm
CORRESP
nhh okuxv
11 Mar 21
Correspondence with SEC
12:00am
UPLOAD
kei6pqekkxg hjo81b9p
9 Mar 21
Letter from SEC
12:00am
F-1
olar5hij4hd9
8 Mar 21
Registration statement (foreign)
9:50pm
6-K
bolab1 hi
26 Feb 21
Current report (foreign)
8:28am
D
c3pheb9q494gbobnl
18 Feb 21
$45.5M in equity, sold $45.5M, 12 investors
11:18am
SC 13G
4swh8oqxp3h0a4q6ji4
17 Feb 21
Silence Therapeutics / Keith Robert Napier ownership change
3:53pm